Abstract
It istrue that patients who are undergoing anticoagulationtherapy will gain additional benefit from the oral admin-istration of vitamin B12. The prevalence of atrialfibrillation from the community aged 65 years or older isreported as 4.7%, and more than half of them are eligiblefor anticoagulation therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
